LAMATTINA JOHN L 4
4 · LIGAND PHARMACEUTICALS INC · Filed Jun 18, 2024
Insider Transaction Report
Form 4
LAMATTINA JOHN L
Director
Transactions
- Award
Common Stock
2024-06-14+1,252→ 29,515 total - Award
Non-Qualified Stock Option (right to buy)
2024-06-14+5,444→ 5,444 totalExercise: $80.06Exp: 2034-06-14→ Common Stock (5,444 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
- [F2]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.